Navigation Links
Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
Date:10/6/2009

the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, expanding to include all patients undergoing chemotherapy and radiotherapy, is estimated to be in excess of $5 billion world-wide.

"We are excited about iMedicor's ability to introduce MuGard more rapidly and to a broad physician audience than we would expect through traditional distribution channels," said Access' CEO Jeffrey Davis. "We believe through this new marketing partnership with iMedicor, Access will be able to reach a broad spectrum of oncologists, radiation oncologists and other key clinicians in a very cost-effective manner, to utilize the medical education aspects of the system to educate about oral mucositis and MuGard, and to accelerate commercial uptake in the US market."

About iMedicor:

iMedicor is the only HIPAA-compliant solution for interoperable health information transfer that is offered to physicians, healthcare providers and patients at no cost. The iMedicor portal enables disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; pharmaceutical companies to deliver customized educational marketing programs to more than 730,000 healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner. More information on iMedicor is available at www.imedicor.com.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' p
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ShowerBuddy - Affordable, Accessible Bathing
2. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
3. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
4. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
5. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
6. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
7. First U.S. Patients Enrolled in the REALISM Continued Access Study
8. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
9. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
10. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
11. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 17, 2014   Headquartered ... Inc. (OTC: GWPC) is a diversified company.  WholeHEALTH ... convenience of advanced technology and proven expertise of ... business of health and wellness.  WholeHEALTH Products, comprehensive ... doctors, clinics and healthcare centers, and 8 retail ...
(Date:11/18/2014)... , Nov. 18, 2014  Cardica, Inc. (Nasdaq: ... Cardica Board has approved management,s recommendation to shift ... of the MicroCutter XCHANGE® 30 surgical stapler to ... launch.  As a result, Cardica has temporarily suspended ... its latest iteration of the MicroCutter XCHANGE 30 ...
(Date:11/18/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the receipt of approval from the U.S. Food and ... IDEAL IMPLANT ® Saline-filled Breast Implant ... existing augmentation implants. The FDA approval of the IDEAL ... studies and data including a U.S. clinical trial that ...
Breaking Medicine Technology:WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 3
... 29, 2011 As small businesses struggle to afford ... concern that forthcoming Essential Health Benefits regulations could include ... to raise prescription drug costs, the Pharmaceutical Care ... (PBMs) administer drug benefits for thousands of small businesses ...
... JOLLA, Calif., Sept. 29, 2011 Synthetic Genomics Vaccines, ... next generation vaccines using genomic sequencing and synthetic genomic ... been appointed as president.  Dr. Farah brings extensive vaccine ... executive management experience in the biotechnology industry to SGVI. ...
Cached Medicine Technology:Some Essential Benefits Rules Could Worry Small Businesses 2Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President 2
(Date:11/18/2014)... TX (PRWEB) November 18, 2014 ... advice and insights, adding to the company's reputation ... Explore everything the blog has to offer at ... through all the information concerning the Affordable Care ... blog aims to inform the public about a ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... An experimental antibody drug could prove effective at lowering ... effects with cholesterol-lowering statin medications. That,s the conclusion ... Heart Association annual meeting in Chicago. The drug, ... most widely used alternative to statins, Zetia, said lead ...
(Date:11/18/2014)... Women who started smoking at a young age may ... a new study suggests. About 29 percent of ... suspected as a risk factor for severe menstrual pain, ... new study said. The researchers analyzed data from ... women,s health in Australia. About 14 percent of the ...
(Date:11/18/2014)... GA (PRWEB) November 18, 2014 ... focused on using the telehealth platform to bring ... Because of this passion, GPT created Global Partnership ... utilizing GPT’s already existing telehealth network. GPTM ... orphanages, hospitals overseas, and disaster relief organizations. ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 Sometimes at ... situations with print devices like unforeseen error messages or ... don't have time to find another printer and they ... The IT department is likely tied up with other ... , That’s where Electronic Systems, Inc. (ESI) ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2
... Researchers at the University of Florida and Metagenics Inc. today ... combined with a low-glycemic, Mediterranean-style diet is almost twice as ... risk factors for cardiovascular disease, the leading cause of death ... medical food UltraMeal PLUS 360 is 40 percent more likely ...
... May 19 (HealthDay News) -- Summer fun can take a ... a common infection that accounts for almost $500 million in ... report. Swimmer,s ear results in 2.4 million doctor ... average of $200, according to the report from the U.S. ...
... FL (May 19, 2011)Researchers from the University of Miami (UM) ... different teaching models for children with Autism Spectrum Disorder (ASD). ... the fidelity of treatment models for preschoolers with autism. ... the journal Research in Autism Spectrum Disorders . ...
... ARBOR, Mich. A primary reason that head and neck ... chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive ... Indian spice curcumin can help cells overcome that resistance. ... head and neck cancer cell lines, they were able to ...
... have been diagnosed with poor sperm quality and who are ... Researchers have found that while cell phone use appears to ... may also lead to low sperm quality and a decrease ... puzzling," says Rany Shamloul, a postdoctoral fellow in the Department ...
... Crohn,s patients in a research study at Penn ... a chronic inflammatory condition of the gastrointestinal tract ... loss. Treatments for Crohn,s disease are designed to ... rare but serious side effects, including infections and ...
Cached Medicine News:Health News:Breakthrough medical food reverses risk of heart disease and diabetes 2Health News:Breakthrough medical food reverses risk of heart disease and diabetes 3Health News:Swimmer's Ear Costs Up to $500 Million a Year in U.S. 2Health News:Validating preschool programs for children with autism 2Health News:Curcumin compound improves effectiveness of head and neck cancer treatment, U-M study finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Medicine Products: